Abstract LB-331: Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
By S. Seshagiri, Eric W. Stawiski, Leonard D. Goldstein, S. Durinck, Z. Modrusan, Florian Gnad, Thong T. Nguyen, B. Jaiswal, A. Rienzo, W. Richards and 1 more. 2016
831 citations recorded by the source corpus.
Subfields: Biotechnology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/2326dd52457241fd53b9274eb7109551e3199709
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
- Brent R. Stockwell
- Xuejun Jiang
- D. Tang
- R. Kang
- Guido Kroemer
- Scott J. Dixon
- M. Conrad
- Tal Hirschhorn
Citations in the corpus
- YAP/TAZ at the roots of cancer (2016, background): “((Bueno et al., 2016) IHC: YAP levels are upregulated in about 70% of mesotheliomas (Fujii et al., 2012; Murakami et al., 2011) YAP knockdown impairs the growth of mesothelioma cell lines Osteosarcoma (OS) None reported IHC: YAP levels are upregulated in about 80% of OS compared to normal bone…”
- Intercellular interaction dictates cancer cell ferroptosis via Merlin-YAP signalling (2019, positive): “As loss of Merlin frequently drives mesothelioma 10,11 , we examined whether Merlin status could predict mesothelioma sensitivity to ferroptosis.”